Pacira BioSciences OverviewPacira BioSciences EBIT
EBIT (Earnings Before Interest and Taxes) analysis for PCRX.
Quarterly EBIT
$6.90M
↓ 44.52% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
$19.65M
↑ 129.43% YoY
Trailing 12 months ending Mar 31, 2026
Pacira BioSciences OverviewEBIT (Earnings Before Interest and Taxes) analysis for PCRX.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026